Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Genentech, Inc.
Indiana University
Corvus Pharmaceuticals, Inc.
Celldex Therapeutics